NVO has been in the news 333% more than usual
May 02, 2025, 6:32 AM
8.97%
What does NVO do
It seems that there is no content provided for summarization. Please provide the text you would like me to summarize.
NVO has been in the news recently: CVS Health will make Novo Nordisk's Wegovy the preferred GLP-1 obesity medication on its largest formularies starting July 1, 2025. Despite this partnership, investor sentiment towards Novo Nordisk remains cautious, reflecting broader market concerns.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.